Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality

BACKGROUND: An implantable cardioverter defibrillator (ICD) is recommended for patients with symptomatic heart failure with ejection fraction ≤35% despite optimal medical therapy. More recently, the benefits of ICDs have been questioned in nonischemic cardiomyopathy (CM). AIM: To examine the inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattsson, Gustav, Magnusson, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027920/
https://www.ncbi.nlm.nih.gov/pubmed/31891421
http://dx.doi.org/10.1111/pace.13869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027920/
https://www.ncbi.nlm.nih.gov/pubmed/31891421
http://dx.doi.org/10.1111/pace.13869

Ejemplares similares